David A. Siegel Wave Life Sciences Ltd. Call Options Transaction History
Two Sigma Advisers, LP
- $42.5 Billion
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding WVE
# of Institutions
132Shares Held
71.8MCall Options Held
86.1KPut Options Held
20.1K-
Lee Ainslie Maverick Capital LTD | Dallas, Tx7.69MShares$38.4 Million0.94% of portfolio
-
M28 Capital Management LP Stamford, CT7MShares$34.9 Million40.53% of portfolio
-
Black Rock Inc. New York, NY6.38MShares$31.8 Million0.0% of portfolio
-
683 Capital Management, LLC New York, NY5.35MShares$26.7 Million2.81% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA5.2MShares$26 Million0.06% of portfolio
About Wave Life Sciences Ltd.
- Ticker WVE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 86,820,096
- Market Cap $433M
- Description
- Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides through PRISM, a discovery and drug developing platform. It is developing oligonucleotides target ribonucleic acid to reduce the expression of disease-promoting proteins or restore the production of functional pr...